Veristat Case Study
Veristat implemented Merative's Zelta cloud-based clinical data management platform — covering electronic data capture, clinical operations tools (RTSM, CTMS, eTMF), and patient/provider engagement (eCOA/ePRO, eConsent) — to gain efficiency and control over its clinical trials, per the page headline ("Learn how Veristat gained efficiency and control over its clinical trials"). The fetched page gives no specific problem detail, numbers, or quotes; the full results are only in a downloadable PDF that was not reachable via fetch.
Merative is the former IBM Watson Health, now an independent company behind the MarketScan claims database and the Zelta clinical-trial platform.
This sits in the Data Providers stage of the AI use-case lifecycle: Named examples from the real-world-data, claims and competitive-intelligence providers pharma AI systems are trained on, benchmarked against, or run inside of.
Published by Merative on its own site — read the original case study on merative.com ↗
Note: Landing page only; no numeric outcomes or problem detail visible — full case study is a gated PDF not reachable via WebFetch.
Related use cases
- 01Boehringer Ingelheim case study
- 02Thought Leadership - MarketScan
- 03How one Canadian research center increased their sample size and strengthened insights
- 04Examining Variations in Elective Surgery Prices Across the U.S.
- 05Getting ahead of drug supply challenges
- 06served its expanding clientele with a modular clinical development solution